Medicine
Eucrisa 2% ointment
Eucrisa 2% ointment is a prescription medicine containing Crisaborole for topical use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C–25°C (68°F–77°F), excursions permitted to 15°C–30°C (59°F–86°F).
Key facts
- Active ingredient (INN)
- Crisaborole
- Brand
- Eucrisa
- Strength
- 2%
- Dosage form
- Ointment
- Route
- Topical
- Packs
- 1 tube, 6 tubes and 1 more
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturer
- Pfizer Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20°C–25°C (68°F–77°F), excursions permitted to 15°C–30°C (59°F–86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D11AH06 Crisaborole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 January 2017
- Identifiers
- RxCUI 1865957, 1865962DailyMed set ID 609b77de-1ca3-4783-b8f5-01a9c0f1d77dNDC 55724-211Application NDA207695
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 100 g in 1 tube | 55724-211-11 | Pfizer Laboratories | 30 January 2017 |
| 1 tube in 1 carton / 60 g in 1 tube | 55724-211-21 | Pfizer Laboratories | 30 January 2017 |
| 1 tube in 1 carton / 60 g in 1 tube | 55724-211-23 | Pfizer Laboratories | 30 January 2017 |
| 6 tube in 1 carton / 2.5 g in 1 tube | 55724-211-42 | Pfizer Laboratories | 30 January 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Crisaborole is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. It is available as ointment for topical use. MedsAcross supplies Crisaborole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CrisaboroleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Eucrisa prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
Need Eucrisa 2% ointment for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.